New Zealand News
-
Health committee gives suggestion to boost NZ's choking clinical trials sector
New Zealand | Analysis | By BioSpectrum Bureau | 4 Comment | 20 Nov, 2012
New Zealand's Health Committee submitted a 62-page report to New Zealand's Parliament making necessary recommendations t...Read more
-
NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds
New Zealand | Regulatory | By BioSpectrum Bureau | 2 Comment | 01 Jun, 2012
Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, ant...Read more
-
Medigene, SynCore expand deal for Veregen
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013
Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expa...Read more
-
Aus, NZ progress on joint regulatory agency
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012
Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic...Read more
-
Dr Frances Guyett to head NZ innovation hub
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2012
Singapore: New Zealand Health Innovation Hub has appointed Dr Frances Guyett as its chief executive. "After an extensive...Read more
-
Real-Time Location Systems are a big hit in Asia
New Zealand | Analysis | By BioSpectrum Bureau | 4 Comment | 01 Mar, 2013
Singapore: Rising costs are compelling hospitals in South East Asia, Australia and New Zealand (ANZ) to streamline their...Read more
-
NZ firm to raise funds for Australia trial
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 t...Read more
-
LanzaTech secures $15 mn debt financing from WTI
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: LanzaTech, a pioneer in waste-to-fuels and chemicals technology, closed $15 million in debt financing from W...Read more
-
Asia vaccine strategists call for collaboration
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...Read more
-
Clinical Network Services acquires Beltas' assets
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2013
Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the plann...Read more
-
Clinical Network Services acquires BELTAS' business assets
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealan...Read more
-
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 18 May, 2012
Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from waste gases, has for the second year in a row be...Read more
-
5 major policy developments of 2012
New Zealand | Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Dec, 2012
The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken...Read more
-
What the future holds for the APAC CRO market?
New Zealand | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Trial begins for vaccine that builds gluten tolerance
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical tria...Read more
-
New Zealand approves stem cell drug Prochymal
New Zealand | Regulatory | By BioSpectrum Bureau | 6 Comment | 15 Jun, 2012
Singapore: Osiris Therapeutics has received consent from New Zealand to market its first-in-class stem cell therapy Proc...Read more
-
IMCD acquires Aussie pharma distributor
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered specia...Read more
-
NZ Smart device company receives $2.5m fund
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
‎Singapore: Asia Pacific healthcare fund manager, BioScience Managers have plans to make investment of US$2.5 mill...Read more
